Therapeutic Areas: Neurology

Choose Therapeutic Area
Infectious diseases incl. Covid-19
Rare diseases
Cromos Pharma offers a wide range of services designed to support clinical trials for neurological disorders

Our key offerings and capabilities include:

  • Study Design and Protocol Development: Cromos Pharma works with sponsors to develop study protocols, including study design, patient selection criteria, and study endpoints.
  • Site Selection and Management: We help sponsors select clinical trial sites across our wide geographies and manage the study conduct at those sites, including site initiation, monitoring, and closeout.
  • Regulatory Support: Cromos Pharma provides individualized support for regulatory submissions in a wide range of jurisdictions, including IND/EMA/Local RA filings, and assists with regulatory compliance throughout the study.
  • Patient Recruitment and Retention: We offer specialized services for patient recruitment and retention, such as patient registries, social media campaigns, and patient engagement programs.
  • Medical Monitoring and Safety Oversight: Cromos Pharma provides medical monitoring and safety oversight for clinical trials, including adverse event management, safety reporting, and medical review.
  • Imaging and Biomarker Analysis: Cromos Pharma works with reliable partners to provide imaging and biomarker analysis services, including neuroimaging and genomic analysis.
  • Project Management: To ensure the successful execution of clinical trials we provide project management services, including budget and timeline management.

Cromos Pharma helps its sponsors in advancing the development of new treatments for neurological disorders by providing specialized expertise and services that enable the conduct of high-quality clinical trials that fully comply with regulatory requirements and generate meaningful data to support the development of new therapies.

Our neuroscience experience includes:
    • Acute cerebrovascular event
    • Acute Pain
    • Acute traumatic cervical spinal cord injury
    • Alzheimer’s Disease
    • Aneurysmal subarachnoid hemorrhage
    • Autism Spectrum Disorder
    • Chronic Pain
    • Epilepsy
    • Fabry Disease
    • Intracranial aneurysms
    • Memory Impairment
    • Mild Cognitive Impairment
    • Multiple Sclerosis
    • Parkinson’s Disease
    • Stroke
    • Vertibrogenic algic syndrome

Rare neurologic diseases:

    • Duchenne muscular dystrophy
    • Leigh Syndrome
    • Myasthenia Gravis
    • Spinal muscular atrophy
    • Tourette syndrome
Cromos Pharma Neurology experience in the last five years
Clinical Sites
our Success story
Relapsing-Remitting Multiple Sclerosis
Click to openclose
Why Cromos Pharma
  • We are the only CRO to offer “No Patients, No Payment” risk sharing program, where the sponsor pays only if we deliver on our milestones.
  • We have the scientific and clinical expertise to support your clinical studies, from early to late phase, from single- to multi-country execution strategies.
  • By leveraging our international expertise, we deliver unparalleled results through diligent feasibility analysis, rapid startup, and accelerated recruitment, while utilizing proactive risk management strategies and maintaining the highest data quality.
  • Our team has vast expertise in organizing scientific advisory board meetings of key opinion leaders, clinicians, and industry stakeholders.



more therapeutics